Gentler radiation may boost lymphoma treatment
NCT ID NCT04054167
First seen Dec 23, 2025 · Last updated Jun 13, 2026 · Updated 27 times
Summary
This study looks at whether a very low dose of radiation, given before or after drug therapy, can help control mantle cell lymphoma that has returned or stopped responding to treatment. About 51 adults with this type of cancer will receive ultra low dose radiation, which aims to shrink tumors with fewer side effects than standard radiation. The main goal is to see how many patients have their tumors shrink or disappear within the radiated area three months after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MANTLE CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.